Testing effectiveness (Phase 2)UnknownNCT01830504What this trial is testingPhase II Pilot Open LabelWho this might be right forThyroid Cancers Hospices Civils de Lyon 47
Testing effectiveness (Phase 2)Study completedNCT01164176What this trial is testingEverolimus in Treating Patients With Locally Advanced or Metastatic Thyroid CancerWho this might be right forHead and Neck Cancer Yonsei University 40
Not applicableLooking for participantsNCT02012699What this trial is testingIntegrated Cancer Repository for Cancer ResearchWho this might be right forPancreatic CancerThyroid CancerLung Cancer+47 more University of Nebraska 999,999
Testing effectiveness (Phase 2)WithdrawnNCT03838692What this trial is testingPonatinib in Advanced or Metastatic Medullary Thyroid CancerWho this might be right forMedullary Thyroid Cancer Antonio Fojo
Not applicableLooking for participantsNCT06405217What this trial is testingRecombinant Human Thyroid Stimulating Hormone for Radioiodine 131I TreatmentWho this might be right forDTC - Differentiated Thyroid CancerThyroid Stimulating; Hormone, CRadiotherapy; Complications Nanjing First Hospital, Nanjing Medical University 30
Post-approval studies (Phase 4)Study completedNCT01496313What this trial is testingTo Compare The Effects Of Two Doses Of Vandetanib In Patients With Advanced Medullary Thyroid CancerWho this might be right forThyroid Cancer Sanofi 81
Testing effectiveness (Phase 2)Study completedNCT00094055What this trial is testingStudy of the Anti-angiogenesis Agent AG-013736 in Patients With Metastatic Thyroid CancerWho this might be right forThyroid Neoplasms Pfizer 60
Testing effectiveness (Phase 2)Looking for participantsNCT07235566What this trial is testingMRG003 and Pucotenlimab to Treat Locally Advanced or Metastatic ATC/PDTCWho this might be right forThyroid Cancer Fudan University 60
Early research (Phase 1)Study completedNCT00005842What this trial is testingTrastuzumab Plus R115777 in Treating Patients With Advanced or Metastatic CancerWho this might be right forCancer National Cancer Institute (NCI) 24
Testing effectiveness (Phase 2)Ended earlyNCT03787303What this trial is testingStudy of Euthyroid Hypothyroxinemia in Metastatic Breast CarcinomaWho this might be right forMetastatic Breast CancerThyroid Dysfunction Aultman Health Foundation 7
Not applicableStudy completedNCT02442661What this trial is testingClinical Validation of a Predictive Model for the Presence of Cervical Lymph Node Metastasis in Papillary Thyroid CancerWho this might be right forPapillary Thyroid Cancer University of Colorado, Denver 103
Testing effectiveness (Phase 2)UnknownNCT01263951What this trial is testingStudy of Everolimus and Sorafenib in Patients With Advanced Thyroid Cancer Who Progressed on Sorafenib AloneWho this might be right forDifferentiated Thyroid Cancer Thomas Jefferson University 35
Early research (Phase 1)Active Not RecruitingNCT03170960What this trial is testingStudy of Cabozantinib Alone or in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid TumorsWho this might be right forUrothelial CarcinomaRenal Cell CarcinomaNon-Small Cell Lung Cancer+11 more Exelixis 914
Large-scale testing (Phase 3)Active Not RecruitingNCT04940052What this trial is testingStudy of Efficacy and Safety of Dabrafenib in Combination With Trametinib in Previously Treated Patients With Metastatic, Radio-active Iodine Refractory BRAF V600E Mutation Positive Differentiated Thyroid CancerWho this might be right forDifferentiated Thyroid Cancer (DTC) Novartis Pharmaceuticals 153
Not applicableStudy completedNCT02592356What this trial is testingEffect of Cabozantinib S-Malate or Lenvatinib Mesylate on Weight and Body Composition in Patients With Metastatic Endocrine CancerWho this might be right forDifferentiated Thyroid Gland CarcinomaMalignant Adrenal Gland PheochromocytomaMalignant Paraganglioma+1 more M.D. Anderson Cancer Center 23
Not applicableStudy completedNCT05191927What this trial is testingA Nomogram Model to Predict Central Lymphnode Metastasis in Thyroid Papillary CarcinomaWho this might be right forThyroid Papillary Carcinoma Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 1,200
Not applicableStudy completedNCT06791174What this trial is testingTumor Microenvironmental Collagen Signature to Predict Thyroid Cancer Superior Mediastinal Lymph Node MetastasisWho this might be right forThyroid Cancer The First Affiliated Hospital of Zhengzhou University 181
Early research (Phase 1)Study completedNCT03122496What this trial is testingImmunotherapy and Stereotactic Body Radiotherapy (SBRT) for Metastatic Anaplastic Thyroid CancerWho this might be right forMetastatic Anaplastic Thyroid Cancer Memorial Sloan Kettering Cancer Center 13
Testing effectiveness (Phase 2)Study completedNCT01661179What this trial is testingEvaluate the Safety and Tolerability of Vandetanib in Japanese Patients With Medullary Thyroid CarcinomaWho this might be right forUnresectable Locally Advanced or Metastatic, Medullary Thyroid Carcinoma Genzyme, a Sanofi Company 14
Testing effectiveness (Phase 2)UnknownNCT05659186What this trial is testingPD-1 Inhibitor and Anlotinib Combined With Multimodal Radiotherapy in Recurrent or Metastatic Anaplastic Thyroid CancerWho this might be right forThyroid Cancer West China Hospital 20